151 related articles for article (PubMed ID: 25801354)
1. Detection of Circulating Tumor Cells at Surgery and at Follow-Up Assessment to Predict Survival After Two-Stage Liver Resection of Colorectal Liver Metastases.
Brudvik KW; Seeberg LT; Hugenschmidt H; Renolen A; Schirmer CB; Brunborg C; Bjørnbeth BA; Borgen E; Naume B; Waage A; Wiedswang G
Ann Surg Oncol; 2015 Nov; 22(12):4029-37. PubMed ID: 25801354
[TBL] [Abstract][Full Text] [Related]
2. Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases.
Seeberg LT; Brunborg C; Waage A; Hugenschmidt H; Renolen A; Stav I; Bjørnbeth BA; Borgen E; Naume B; Brudvik KW; Wiedswang G
Ann Surg Oncol; 2017 Aug; 24(8):2113-2121. PubMed ID: 28258416
[TBL] [Abstract][Full Text] [Related]
3. Circulating Tumor Cells in Patients Undergoing Resection of Colorectal Cancer Liver Metastases. Clinical Utility for Long-Term Outcome: A Prospective Trial.
Arrazubi V; Mata E; Antelo ML; Tarifa A; Herrera J; Zazpe C; Teijeira L; Viudez A; Suárez J; Hernández I; Vera R
Ann Surg Oncol; 2019 Sep; 26(9):2805-2811. PubMed ID: 31209673
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor cells in patients with colorectal liver metastasis predict impaired survival.
Seeberg LT; Waage A; Brunborg C; Hugenschmidt H; Renolen A; Stav I; Bjørnbeth BA; Brudvik KW; Borgen EF; Naume B; Wiedswang G
Ann Surg; 2015 Jan; 261(1):164-71. PubMed ID: 24509211
[TBL] [Abstract][Full Text] [Related]
5. Disseminated tumor cells in the bone marrow negatively influence survival after resection of colorectal liver metastases.
Hinz S; Bockhorst J; Röder C; Egberts JH; Schafmayer C; Küchler T; Becker T; Kalthoff H
Ann Surg Oncol; 2012 Aug; 19(8):2539-46. PubMed ID: 22395998
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer.
Pesta M; Fichtl J; Kulda V; Topolcan O; Treska V
Anticancer Res; 2013 May; 33(5):2239-43. PubMed ID: 23645782
[TBL] [Abstract][Full Text] [Related]
7. Central, But Not Peripheral, Circulating Tumor Cells are Prognostic in Patients Undergoing Resection of Colorectal Cancer Liver Metastases.
Connor AA; McNamara K; Al-Sukhni E; Diskin J; Chan D; Ash C; Lowes LE; Allan AL; Zogopoulos G; Moulton CA; Gallinger S
Ann Surg Oncol; 2016 Jul; 23(7):2168-75. PubMed ID: 26714949
[TBL] [Abstract][Full Text] [Related]
8. Two-stage resection for bilobar colorectal liver metastases: R0 resection is the key.
Tsim N; Healey AJ; Frampton AE; Habib NA; Bansi DS; Wasan H; Cleator SJ; Stebbing J; Lowdell CP; Jackson JE; Tait P; Jiao LR
Ann Surg Oncol; 2011 Jul; 18(7):1939-46. PubMed ID: 21298352
[TBL] [Abstract][Full Text] [Related]
9. Unique localization of circulating tumor cells in patients with hepatic metastases.
Jiao LR; Apostolopoulos C; Jacob J; Szydlo R; Johnson N; Tsim N; Habib NA; Coombes RC; Stebbing J
J Clin Oncol; 2009 Dec; 27(36):6160-5. PubMed ID: 19884529
[TBL] [Abstract][Full Text] [Related]
10. Right portal vein embolization before right hepatectomy for unilobar colorectal liver metastases reduces the intrahepatic recurrence rate.
Oussoultzoglou E; Bachellier P; Rosso E; Scurtu R; Lucescu I; Greget M; Jaeck D
Ann Surg; 2006 Jul; 244(1):71-9. PubMed ID: 16794391
[TBL] [Abstract][Full Text] [Related]
11. Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity.
Gröbe A; Blessmann M; Hanken H; Friedrich RE; Schön G; Wikner J; Effenberger KE; Kluwe L; Heiland M; Pantel K; Riethdorf S
Clin Cancer Res; 2014 Jan; 20(2):425-33. PubMed ID: 24218516
[TBL] [Abstract][Full Text] [Related]
12. Two-stage hepatectomy for multiple bilobar colorectal liver metastases.
Narita M; Oussoultzoglou E; Jaeck D; Fuchschuber P; Rosso E; Pessaux P; Marzano E; Bachellier P
Br J Surg; 2011 Oct; 98(10):1463-75. PubMed ID: 21710481
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors after resection of colorectal liver metastases following preoperative second-line chemotherapy: Impact of RAS mutations.
Passot G; Chun YS; Kopetz SE; Overman MJ; Conrad C; Aloia TA; Vauthey JN
Eur J Surg Oncol; 2016 Sep; 42(9):1378-84. PubMed ID: 27358198
[TBL] [Abstract][Full Text] [Related]
14. Correlation of circulating angiogenic factors with circulating tumor cells and disease recurrence in patients undergoing curative resection for colorectal liver metastases.
Rahbari NN; Reissfelder C; Mühlbayer M; Weidmann K; Kahlert C; Büchler MW; Weitz J; Koch M
Ann Surg Oncol; 2011 Aug; 18(8):2182-91. PubMed ID: 21598056
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of outcomes and treatment safety of patients with metastatic colorectal cancer to the liver with estimation of prognostic factors.
Zeman M; Maciejewski A; Półtorak S; Kryj M
Pol Przegl Chir; 2013 Jun; 85(6):333-9. PubMed ID: 23828415
[TBL] [Abstract][Full Text] [Related]
16. Importance of circulating tumor cells in newly diagnosed colorectal cancer.
van Dalum G; Stam GJ; Scholten LF; Mastboom WJ; Vermes I; Tibbe AG; De Groot MR; Terstappen LW
Int J Oncol; 2015 Mar; 46(3):1361-8. PubMed ID: 25572133
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Perioperative Red Blood Cell Transfusions on Long-Term Outcomes after Hepatectomy for Colorectal Liver Metastases.
Hallet J; Tsang M; Cheng ES; Habashi R; Kulyk I; Hanna SS; Coburn NG; Lin Y; Law CH; Karanicolas PJ
Ann Surg Oncol; 2015 Nov; 22(12):4038-45. PubMed ID: 25752895
[TBL] [Abstract][Full Text] [Related]
18. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.
Cohen SJ; Punt CJ; Iannotti N; Saidman BH; Sabbath KD; Gabrail NY; Picus J; Morse M; Mitchell E; Miller MC; Doyle GV; Tissing H; Terstappen LW; Meropol NJ
J Clin Oncol; 2008 Jul; 26(19):3213-21. PubMed ID: 18591556
[TBL] [Abstract][Full Text] [Related]
19. Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.
Krishnamurthy S; Cristofanilli M; Singh B; Reuben J; Gao H; Cohen EN; Andreopoulou E; Hall CS; Lodhi A; Jackson S; Lucci A
Cancer; 2010 Jul; 116(14):3330-7. PubMed ID: 20564098
[TBL] [Abstract][Full Text] [Related]
20. Circulating CD95-ligand as a potential prognostic marker for recurrence in patients with synchronous colorectal liver metastases.
Hoogwater FJ; Snoeren N; Nijkamp MW; Gunning AC; VAN Houdt WJ; DE Bruijn MT; Voest EE; VAN Hillegersberg R; Kranenburg O; Rinkes IH
Anticancer Res; 2011 Dec; 31(12):4507-12. PubMed ID: 22199323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
